hla class

citrullination

reality ar

leaf litter

hbv reactivation

mhc-i

graminis

These polymorphic residues in the binding site of the MHC class II molecules of the affected patients appear capable of binding some peptide sequences of the recombinant vaccine peptides they received and may be responsible for hepatitis B vaccine triggering development of RA in these cases. Recombinant hepatitis B vaccine may trigger the development of RA in MHC class II genetically susceptible individuals.

The development of rheumatoid arthritis after recombinant hepatitis B vaccination.